These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15869920)

  • 1. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.
    Valenta A; Roschger P; Fratzl-Zelman N; Kostenuik PJ; Dunstan CR; Fratzl P; Klaushofer K
    Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.
    Kostenuik PJ; Capparelli C; Morony S; Adamu S; Shimamoto G; Shen V; Lacey DL; Dunstan CR
    Endocrinology; 2001 Oct; 142(10):4295-304. PubMed ID: 11564687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
    Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
    Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
    Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ
    J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat.
    Campbell GM; Bernhardt R; Scharnweber D; Boyd SK
    Bone; 2011 Aug; 49(2):225-32. PubMed ID: 21515436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strontium and bone nanostructure in normal and ovariectomized rats investigated by scanning small-angle X-ray scattering.
    Bünger MH; Oxlund H; Hansen TK; Sørensen S; Bibby BM; Thomsen JS; Langdahl BL; Besenbacher F; Pedersen JS; Birkedal H
    Calcif Tissue Int; 2010 Apr; 86(4):294-306. PubMed ID: 20221590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
    Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
    J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
    Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.
    Samadfam R; Xia Q; Goltzman D
    J Bone Miner Res; 2007 Jan; 22(1):55-63. PubMed ID: 17014384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice.
    Alexander JM; Bab I; Fish S; Müller R; Uchiyama T; Gronowicz G; Nahounou M; Zhao Q; White DW; Chorev M; Gazit D; Rosenblatt M
    J Bone Miner Res; 2001 Sep; 16(9):1665-73. PubMed ID: 11547836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
    Han X; Xu Y; Wang J; Pei X; Yang R; Li N; Li Y
    Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
    Cheng PT; Chan C; Müller K
    J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function.
    Shimizu-Ishiura M; Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2002; 51(5):315-25. PubMed ID: 12455916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.